EURENSA integrated the new demands of the authorities in its services for the production of economic data.

•      Basic analysis PMSI Extraction of relevant data from the PMSI according to one or more disease (s) (ICD-10 diagnoses GHM), one or more act (s) (CCAM classification) of one or molecule (s) expensive (s) or a correlation diagnosis of acts and expensive drugs.

•      Marketing data analysis:
  • Factorial analysis: PCA, CA, ACM
  • MDS analysis of similarities
  • Correlation, multiple linear regression, PLS
  • Typology, segmentation, discriminant analysis, scoring
  • Trade off, analysis of variance
  • Targeting, segmentation

•      Creation of pharmacoeconomic models: decision trees, Markov model, microsimulation, DES, transmission Model,
•      Implementation and management of cost effectiveness, cost utility, or fiscal impact studies,
•      Sensitivity analysis,
•      Cross analysis with foreign repository: comparison of patients care management, comparison of cost efficiencies,…
•      On line data collection tools, or remote data collection by our phone plateform,
  
•      Data entry, recapture data,
•      Report presentation.